[1]
Cao, R. et al. 2026. Comparison and Synergy of iVAC and CRISPR-Related Tumor Immune Strategies: Value Reassessment Under A Zero Genome Risk Reference. International Journal of Biology and Life Sciences. 17, 2 (Nov. 2026), 44–51. DOI:https://doi.org/10.54097/pnqcf426.